HR+ HER2- Breast Cancer and Triple Negative Breast Cancer, with inclusion of HER2 Low Breast Cancer

Details

Files

Project Status:

Complete

Project Line:

Reimbursement Review

Project Sub Line:

Provisional Funding Algorithm

Project Number:

PH0033-000

Review Type: Panel

Provisional Funding Algorithm
Stakeholder Input Deadline:	August 11, 2023
Draft Report Posted:	October 26, 2023
Stakeholder Feedback Deadline:	November 2, 2023
Final Report Posted:	December 7, 2023

Last Updated : December 7, 2023